Kurt Graves
Director/Miembro de la Junta en SERES THERAPEUTICS, INC. .
Fortuna: - $ al 31/05/2024
Perfil
Kurt C.
Graves is currently the Chairman, President & Chief Executive Officer at I2o Therapeutics, Inc. He is also a Director at Alevium Pharmaceuticals, Inc. and an Independent Director at Seres Therapeutics, Inc. Previously, Mr. Graves held positions such as Executive Chairman & Chief Executive Officer at Intarcia Therapeutics, Inc., Executive Chairman at Biolex Therapeutics, Inc., Chairman at Radius Health, Inc., Director at Pulmatrix Operating Co., Inc., Independent Director at Achillion Pharmaceuticals, Inc., Director at SpringLeaf Therapeutics, Inc., and Executive Director at Astra Merck, Inc. He also served as a Director at Pulmatrix, Inc. and held the role of Product Manager at Merck & Co., Inc. Additionally, he was the Chief Commercial Officer & Executive VP at Vertex Pharmaceuticals, Inc. and the Chief Marketing Officer-Pharmaceuticals Division at Novartis Pharmaceuticals Corp.Mr. Graves obtained his undergraduate degree from Hillsdale College.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SERES THERAPEUTICS INC
-.--% | 04/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Kurt Graves
| Empresas | Cargo | Inicio |
|---|---|---|
| SERES THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/11/2015 |
| Alevium Pharmaceuticals, Inc. | Director/Miembro de la Junta | - |
I2o Therapeutics, Inc.
 I2o Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology I2o Therapeutics, Inc. develops injection pills for biological therapies. It offers revolutionary oral delivery platform such as high bioavailability, low cost of goods, superior drug loading, injection free delivery, readily scalable, and compatible with diverse drug types. The company was founded by Samir Mitragotri, Ravi Srinivasan, Kelly Ibsen, and Tyler Brown in 2019 and is headquartered in Allston, MA. | Director Ejecutivo | 28/08/2023 |
Antiguos cargos conocidos de Kurt Graves.
| Empresas | Cargo | Fin |
|---|---|---|
| RADIUS HEALTH, INC. | Presidente | 23/03/2020 |
| ACHILLION PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 28/01/2020 |
| PULMATRIX, INC. | Director/Miembro de la Junta | 14/06/2016 |
Biolex Therapeutics, Inc.
 Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Biolex Therapeutics, Inc. developed and produced drugs. The company was founded in 1997 and was headquartered in Pittsboro, NC. | Presidente | 01/03/2012 |
SpringLeaf Therapeutics, Inc.
 SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | Director/Miembro de la Junta | 01/01/2012 |
Formación de Kurt Graves.
| Hillsdale College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| PULMATRIX, INC. | Health Technology |
| Empresas privadas | 10 |
|---|---|
Biolex Therapeutics, Inc.
Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Biolex Therapeutics, Inc. developed and produced drugs. The company was founded in 1997 and was headquartered in Pittsboro, NC. | Distribution Services |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | Retail Trade |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Alevium Pharmaceuticals, Inc. | |
I2o Therapeutics, Inc.
I2o Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology I2o Therapeutics, Inc. develops injection pills for biological therapies. It offers revolutionary oral delivery platform such as high bioavailability, low cost of goods, superior drug loading, injection free delivery, readily scalable, and compatible with diverse drug types. The company was founded by Samir Mitragotri, Ravi Srinivasan, Kelly Ibsen, and Tyler Brown in 2019 and is headquartered in Allston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Kurt Graves
